Chemitope Glycopeptide is a Brooklyn-based biotechnology company specializing in the chemical synthesis of glycopeptides for research and clinical development. Leveraging two unique skill sets in carbohydrate and peptide chemistry, we exert atomic-level structural control to produce homogeneous complex glycopeptides. Chemitope’s research and development is focused on exploiting glycosylation in cancer and infectious diseases to develop glycopeptide immunogens for therapeutic and preventative vaccine applications. In addition, we provide comprehensive chemical synthesis and pre-clinical manufacturing support for our partners in academia, biotech, and the pharmaceutical industry.